IV vitamin therapy has surged in popularity, promoted by wellness clinics and concierge services offering everything from energy-boosting drips to hangover cures. The concept is simple: by bypassing ...

An Illinois state jury has today ruled in favor of Boehringer Ingelheim, rejecting claims from two men who alleged that their prostate cancer diagnoses were caused by long-term use of the company’s ...

and the country’s policy priorities in the context of the 2025 Article IV consultation. At the end of the mission, Ms. Sodsriwiboon issued the following statement: “Thanks to the Maldives’ strong ...

It was credited as being the game that almost killed Tomb Raider, and now, thanks to Aspyr, it’s back to rear its ugly head on the Nintendo Switch in Tomb Raider IV-VI Remastered. This second ...

There's something uncanny about dipping "classic" games in a tub of HD paint for the purposes of a remaster. A reboot can completely reinvent an old character, intriguing players in the same way an ...

Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing, ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.